✦ LIBER ✦

COMBINATION OF ASA WITH DABIGATRAN OR RIVAROXABAN INCREASES RISK OF BLEEDING WITHOUT ADDITIONAL BENEFIT OF STROKE REDUCTION IN PATIENTS WITH ATRIAL FIBRILLATION

✍ Scribed by Strunets, Anton; Mirza, Mahek; Cho, Chi; Sra, Jasbir; Jahangir, Arshad

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risks and benefits of combining aspirin

✍ Greg C. Flaker; Michael Gruber; Stuart J. Connolly; Steven Goldman; Sandra Chapa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 117 KB

For people with non-valvular atrial fibr

✍ Sherwood, M.; Piccini, J. P. 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 68 KB

RISK OF STROKE OR TRANSIENT ISCHEMIC ATT

✍ Sardar, Partha; Chatterjee, Saurav; Nairooz, Ramez; Ghosh, Joydeep; J_rn, Wetter 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 888 KB

PCV51 Cost-Effectiveness of Rivaroxaban

✍ Y. Asukai; A. Duran; A. Lloyd; E.J. McLeod; T. Evers; J. Broughton 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

High-dose atorvastatin and risk of atria

✍ Gregory G. Schwartz; Bernard R. Chaitman; Jeffrey J. Goldberger; Michael Messig 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Comparative Validation of a Novel Risk S

✍ Gregory Y.H. Lip; Lars Frison; Jonathan L. Halperin; Deirdre A. Lane 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 268 KB